[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368717-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368717-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","conserved-and-unique-features-of-terminal-telomeric-sequences-in-altpositive-cancer-cells","Conserved and unique features of terminal telomeric sequences in ALTpositive cancer cells","","A significant portion of human cancers relies on the recombination-based ALT (alternative lengthening of telomeres) pathway to sustain telomere length. Despite interest in targeting ALT therapeutically, fundamental knowledge remains limited about the terminal telomere features in ALT-positive cells. Using END-seq, an unbiased sequencing approach, the study defines terminal sequence identity and regulation in ALT cells and reveals conserved canonical telomeric terminal bias and POT1-dependent 5′ end control, independent of elongation mechanism.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/conserved-and-unique-features-of-terminal-telomeric-sequences-in-altpositive-cancer-cells/368717/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/conserved-and-unique-features-of-terminal-telomeric-sequences-in-altpositive-cancer-cells/368717.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this study in ALT-positive cancer cells?","Question",{"text":63,"@type":64},"To define the identity and regulation of terminal chromosome sequences in ALT cells and determine conserved and unique features of their telomeres.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers analyze terminal telomeric sequences in ALT cells?",{"text":68,"@type":64},"They adopted END-seq, an unbiased sequencing-based approach originally used for mapping genome-wide DNA double-strand breaks, to telomere biology.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does POT1 play in telomere end regulation in ALT versus non-ALT cells?",{"text":72,"@type":64},"POT1 is required to preserve precise regulation of the 5′ end in cells maintaining telomere length via the ALT pathway, consistent with observations in non-ALT cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368717,1790218830,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE  \nConserved and unique features of terminal telomeric sequences in ALTpositive cancer cells  \nBenura Azeroglu, Wei Wu†, Raphael Pavani, Ranjodh Singh Sandhu, Tadahiko Matsumoto‡, André Nussenzweig, Eros Lazzerini-Denchi*  \nLaboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, United States  \n*For correspondence:  \n[eros.lazzerinidenchi@nih.gov](eros.lazzerinidenchi@nih.gov)  \n[Present address:](Present address:) †Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China; ‡Kyoto University, Kyoto, Japan  \nCompeting interest: The authors declare that no competing interests exist.  \nFunding: See page 14  \nPreprint posted  \n02 March 2025  \nSent for Review  \n08 March 2025  \nReviewed preprint posted  \n12 May 2025  \nReviewed preprint revised  \n17 July 2025  \nVersion of Record published  \n01 August 2025  \nReviewing Editor: Julia Promisel Cooper, University of Colorado Anschutz Medical Campus, Aurora, United States  \n This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \n\n| eLife Assessment\u003Cbr>This study demonstrates the application of END-seq, originally developed to study genomewide DNA double-strand breaks, to telomere biology; the work packs a punch, concisely demonstrating the utility of this approach and the new insights that can be gained. The authors confirm that telomeres in telomerase-positive cells terminate with 5'-ATC in a Pot1-dependent manner and demonstrate that this principle holds true in telomerase-negative ALT cells as well. S1-END-seq is similarly developed for telomeres, showing that ALT cells harbor several regions of ssDNA. The study is well-executed and convincing, the new insights are fundamental and compelling, and the optimized END-seq approaches will be widely utilized. The work will prompt additional studies that thereviewers look forward to, including combining telomeric END-seq with long-read sequencing to address the distribution and origin of variant telomere repeats and ssDNA along telomeres in ALT and telomerase-positive settings. |\n| --- |\n| Abstract A significant portion of human cancers utilize a recombination-based pathway, alternative lengthening of telomeres (ALT), to maintain telomere length. Targeting the ALT is of growing interest as a cancer therapy, yet a substantial knowledge gap remains regarding the basic features of telomeres in ALT-positive cells. To address this, we adopted END-seq, an unbiased sequencingbased approach, to define the identity and regulation of the terminal sequences of chromosomes in ALT cells. Our data reveal that the terminal portions of chromosomes in ALT cells contain canonical telomeric sequences with the same terminus bias (-ATC) observed in non-ALT cells. Furthermore, as reported for non-ALT cells, POT1 is required to preserve the precise regulation of the 5 ′ end in cells that maintain telomere length using the ALT pathway. Thus, the regulation of the terminal 5 ′ of chromosomes occurs independently of the mechanism of telomere elongation. Additionally, we employed an S1 endonuclease-based sequencing method to determine the presence and origin of single-stranded regions within ALT telomeres. These data shed light on conserved and unique features of ALT telomeres. |\n\nIntroduction  \nTelomeres are the natural ends of eukaryotic chromosomes and are critical for maintaining chromosome integrity (Palm and de Lange, 2008) . Human telomeres consist of 5–15 kilobases of repetitive DNA sequences (5 ′-TTAGGG-3 ′), which serve as a binding platform for an essential protective protein complex named shelterin (Palm and de Lange, 2008) . The terminal portion of chromosomes i","cbCaih8ZPs7kxPuR","https://ap.wps.com/l/cbCaih8ZPs7kxPuR","pdf",5168858,17,"English","# Introduction\n## Telomeres and shelterin\n## 3′ overhang generation\n## Telomere maintenance pathways (telomerase and ALT)","[{\"question\":\"What is the main objective of this study in ALT-positive cancer cells?\",\"answer\":\"To define the identity and regulation of terminal chromosome sequences in ALT cells and determine conserved and unique features of their telomeres.\"},{\"question\":\"How did the researchers analyze terminal telomeric sequences in ALT cells?\",\"answer\":\"They adopted END-seq, an unbiased sequencing-based approach originally used for mapping genome-wide DNA double-strand breaks, to telomere biology.\"},{\"question\":\"What role does POT1 play in telomere end regulation in ALT versus non-ALT cells?\",\"answer\":\"POT1 is required to preserve precise regulation of the 5′ end in cells maintaining telomere length via the ALT pathway, consistent with observations in non-ALT cells.\"}]","Conserved and unique features of terminal telomeric sequences in ALTpositive cancer cells | PDF",1790178170,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e611ea641844b2cb953086e51d276777.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4898b1d26564a2fec76eb65a86f06b11.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/adfcf6d85d8c8c751855df61c958ae3d.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c580a5057cec3a02de881f98a19c2d13.webp",980,1268]